Ignite Creation Date:
2024-05-05 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 9:45 AM
Study NCT ID:
NCT00629252
Status:
TERMINATED
Last Update Posted:
2012-09-17
First Post:
2008-01-21
Brief Title:
The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients
Sponsor:
University of Zurich
Organization:
University of Zurich
Study Overview
Official Title:
None
Status:
TERMINATED
Status Verified Date:
2012-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not enough subjects have been recruited in the expected period
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate whether the atypical antipsychotic and mixed 5-HT2D2 antagonist sertindole modulates or improves both subcortical and cortical information processing in schizophrenic patients who had not or insufficiently responded to previous antipsychotic medication This goal shall be accomplished by investigating the effect of sertindole of both prepulse inhibition of the acoustic startle PPI and P50 suppression of auditory evoked potentials in schizophrenic patients These effects shall be compared to the effect of risperidone and shall also be compared to untreated healthy controls
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007DR1253 | None | None | None |
| E-112007 | None | None | None |